Literature DB >> 17823503

Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy.

Kunihiro Ichinose1, Eiji Kawasaki, Katsumi Eguchi.   

Abstract

Type 1 diabetes mellitus is an autoimmune disease characterized by progressive destruction of pancreatic beta cells by genetic and environmental factors which leads to an absolute dependence of insulin for survival and maintenance of health. Although the majority of mechanisms of beta cell destruction remain unclear, many molecules, including proinflammatory cytokines and chemokines such as tumor necrosis factor alpha and monocyte chemoattractant protein-1, are implicated in the development of beta cell damage. Furthermore, beta cell destruction is enhanced by the Th1 and Th17 subsets of CD4+ T cells. In contrast, there are mechanisms involved in the maintenance of peripheral tolerance by regulatory T cells, the function of which depends on the pleiotropic cytokine transforming growth factor beta. Development and progression of renal injuries in patients with diabetic nephropathy are also associated with several growth factors and proinflammatory cytokines, including tumor necrosis factor alpha, insulin-like growth factor-1, monocyte chemoattractant protein-1, vascular endothelial growth factor, and transforming growth factor beta. Although the pathogenic mechanisms underlying type 1 diabetes and diabetic nephropathy are principally different, i.e., autoimmunity and inflammation, some common factors, including susceptibility genes and proinflammatory cytokines, are involved in both mechanisms, including infiltrating cell recruitment, upregulation of other cytokines and chemokines, or apoptosis. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823503     DOI: 10.1159/000107758

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  30 in total

1.  The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus.

Authors:  Abdolrahim Nikzamir; Alireza Esteghamati; Amir Abbas Hammedian; Touraj Mahmoudi
Journal:  Mol Biol Rep       Date:  2011-05-12       Impact factor: 2.316

2.  Involvement of vascular endothelial nitric oxide synthase in development of experimental diabetic nephropathy in rats.

Authors:  Atul Arya; Harlokesh Naryan Yadav; P L Sharma
Journal:  Mol Cell Biochem       Date:  2011-04-06       Impact factor: 3.396

3.  Corticosterone and exogenous glucose alter blood glucose levels, neurotoxicity, and vascular toxicity produced by methamphetamine.

Authors:  John F Bowyer; Karen M Tranter; Sumit Sarkar; Nysia I George; Joseph P Hanig; Kimberly A Kelly; Lindsay T Michalovicz; Diane B Miller; James P O'Callaghan
Journal:  J Neurochem       Date:  2017-09-21       Impact factor: 5.372

4.  Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells.

Authors:  Tian Lan; Weihua Liu; Xi Xie; Suowen Xu; Kaipeng Huang; Jing Peng; Xiaoyan Shen; Peiqing Liu; Lijing Wang; Pu Xia; Heqing Huang
Journal:  Mol Endocrinol       Date:  2011-10-13

5.  Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus.

Authors:  Christopher G Bell; Andrew E Teschendorff; Vardhman K Rakyan; Alexander P Maxwell; Stephan Beck; David A Savage
Journal:  BMC Med Genomics       Date:  2010-08-05       Impact factor: 3.063

6.  Alzheimer's disease is type 3 diabetes-evidence reviewed.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Diabetes Sci Technol       Date:  2008-11

7.  Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy.

Authors:  Li Qin Tang; Feng Ling Wang; Ling Na Zhu; Fei Lv; Sheng Liu; Shan Tang Zhang
Journal:  Mol Biol Rep       Date:  2012-12-25       Impact factor: 2.316

8.  Integrin targeted delivery of chemotherapeutics.

Authors:  Kai Chen; Xiaoyuan Chen
Journal:  Theranostics       Date:  2011-02-17       Impact factor: 11.556

9.  Korean red ginseng extract alleviates advanced glycation end product-mediated renal injury.

Authors:  Hai Yan Quan; Do Yeon Kim; Sung Hyun Chung
Journal:  J Ginseng Res       Date:  2013-04       Impact factor: 6.060

10.  Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial.

Authors:  Julie Lin; Robert J Glynn; Nader Rifai; JoAnn E Manson; Paul M Ridker; David M Nathan; Debra A Schaumberg
Journal:  Diabetes Care       Date:  2008-09-16       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.